<ѻý>Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?ѻý> News, features, and commentary about cancer-related issues Nov 22, 2024
<ѻý>Treatment of Oligometastatic EGFR-Mutant Lung Cancerѻý> More research needed on role of local therapy in new era of treatment Nov 22, 2024
<ѻý>Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancerѻý> News, features, and commentary about cancer-related issues Nov 15, 2024
<ѻý>'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancerѻý> News, features, and commentary about cancer-related issues Nov 08, 2024
<ѻý>Watch for Psoriasis After Cancer Immunotherapy, Study Saysѻý> PD-1/PD-L1 inhibitors singled out for association Nov 07, 2024
<ѻý>Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancerѻý> News, features, and commentary about cancer-related issues Nov 01, 2024
<ѻý>Year in Review: Non-Small Cell Lung Cancerѻý> A look back at some of the newsworthy developments of 2024 Nov 01, 2024
<ѻý>Early Smoking Cessation After Cancer Diagnosis Tied to Better Survivalѻý> Largest survival benefit observed in patients who entered a cessation program within 6 months Oct 31, 2024
<ѻý>Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retractedѻý> -- News, features, and commentary about cancer-related issues Oct 18, 2024
<ѻý>ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?ѻý> Debate highlights pros and cons of the new recommendation Oct 11, 2024
<ѻý>Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancerѻý> Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone Oct 10, 2024
<ѻý>Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolismѻý> Study raises questions about how to assess patient risk, experts say Oct 08, 2024
<ѻý>Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancerѻý> News, features, and commentary about cancer-related issues Oct 04, 2024
<ѻý>Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLCѻý> Latest negative results emphasize "critical" aspect of immunotherapy timing Oct 02, 2024
<ѻý>FDA Expands Approval of Osimertinib in Lung Cancerѻý> EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
<ѻý>Cancer Diagnoses Slow to Recover From Effects of COVID Pandemicѻý> Actual rates for 2021 lagged behind projections Sep 25, 2024
<ѻý>Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?ѻý> News, features, and commentary about cancer-related issues Sep 19, 2024
<ѻý>Novel Agent Effective for Cancer Wasting Disorderѻý> Cancer patients with cachexia added needed pounds with GDF-15 antibody Sep 18, 2024
<ѻý>Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancerѻý> News, features, and commentary about cancer-related issues Sep 12, 2024
<ѻý>Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLCѻý> Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan Sep 11, 2024
<ѻý>Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLCѻý> However, plinabulin plus docetaxel still "not ready for prime time," expert says Sep 10, 2024
<ѻý>MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLCѻý> Absolute improvement of almost 30%, doubling of duration of response with savolitinib Sep 10, 2024
<ѻý>Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLCѻý> Two-trial analysis shows about a 40% decreased risk of disease recurrence or death Sep 09, 2024
<ѻý>Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLCѻý> Novel agent nearly halved risk of progression as first-line therapy in phase III trial Sep 09, 2024
<ѻý>Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancerѻý> Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy Sep 09, 2024
<ѻý>Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'ѻý> News, features, and commentary about cancer-related issues Aug 30, 2024
<ѻý>Trial Questions Role of Dual Immunotherapy in First-Line NSCLCѻý> In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity Aug 22, 2024
<ѻý>Researchers Challenge USPSTF's Lung Cancer Screening Criteriaѻý> Alternate criteria based on years of smoking has higher sensitivity and specificity, study says Aug 20, 2024
<ѻý>Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancerѻý> Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib Aug 20, 2024
<ѻý>Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggestsѻý> More data for discussion of controversial association between steroids, immunotherapy Aug 19, 2024
<ѻý>FDA Expands Durvalumab Label to Operable Lung Cancerѻý> PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery Aug 16, 2024
<ѻý>No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpireѻý> News, features, and commentary about cancer-related issues Aug 09, 2024
<ѻý>Cancer Screening Costs Over $43 Billion a Year in the U.S., Study Estimatesѻý> Colorectal cancer screening accounted for 64% of the total amount Aug 05, 2024
<ѻý>Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Diesѻý> News, features, and commentary about cancer-related issues Aug 02, 2024
<ѻý>Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Riskѻý> News, features, and commentary about cancer-related issues Jul 26, 2024
<ѻý>FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trialsѻý> Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
<ѻý>A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Tollѻý> News, features, and commentary about cancer-related issues Jul 12, 2024
<ѻý>Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGITѻý> News, features, and commentary about cancer-related issues Jul 05, 2024
<ѻý>Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancerѻý> Discussion highlights insights from the LAURA trial and others on emerging treatments Jul 03, 2024 video
<ѻý>Vapers May Be Less Likely to Undergo Lung Cancer Screeningѻý> "Former smokers who use e-cigarettes remain at increased risk of lung cancer," researchers say Jul 02, 2024